Your browser doesn't support javascript.
loading
Angiosarcoma: A Rare Malignancy Linked to Chemical Exposures.
Tessema, Sophia T; Mahgoub, Abdullahi E; Nakhleh, Rasha.
Afiliação
  • Tessema ST; Neurology, Wayne State University, Detroit, USA.
  • Mahgoub AE; Internal Medicine, Michigan State University / Hurley Medical Center, Flint, USA.
  • Nakhleh R; Internal Medicine & Geriatrics, Oregon Health & Science University, Portland, USA.
Cureus ; 14(5): e25289, 2022 May.
Article em En | MEDLINE | ID: mdl-35755516
ABSTRACT
Angiosarcoma is an exceptionally rare malignancy that accounts for less than 1% of all sarcomas. This case describes a 90-year-old male veteran who presented with a hematoma from a traumatic head injury. This then progressed to an ulcerated bleeding lesion that measured 2.5 cm in diameter with pearly borders and granulation tissue. CT scan of the head and skin biopsy were consistent with the diagnosis of cutaneous angiosarcoma. The patient may have unique exposures from the military training site Camp Lejeune including tetrachloroethylene (PCE), trichloroethylene (TCE), trans-1,2-dichloroethylene, and vinyl chloride predisposing to angiosarcoma. The patient underwent palliative radiation without obvious complications. This case presents an opportunity for further evaluation and understanding of the effects of these exposures and the implications for the health of veterans and aging populations. Patient outcomes may be improved with earlier diagnosis and aggressive treatment.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos